European Academy of Dermatology and Venereology Congress

A portable photodynamic therapy device for at-home treatment of basal cell carcinoma was shown to be efficacious in a pilot study presented at the EADV virtual congress.

Weekly dupilumab showed long-term safety and efficacy in atopic dermatitis patients in an open-label extension study presented at the EADV Congress virtual meeting.

Secukinumab 300 mg administered with an auto-injector pen showed significant efficacy and tolerability compared with placebo, according to clinical trial results presented at the EADV Congress virtual meeting.

The use of a ceramide-containing skincare routine reduced dryness and erythema caused by topical acne medications, according to a poster presented at the EADV Congress virtual meeting.